Literature DB >> 10873887

Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients.

H M Ramsay1, A A Fryer, S Reece, A G Smith, P N Harden.   

Abstract

A single-center, cross-sectional, longitudinal study was conducted to determine the prevalence, annual incidence, and clinical risk factors for skin cancer in a white renal transplant population. One hundred eighty-two white patients (95% of population) with functioning allografts, a mean age at transplantation of 38.9 +/- 15. 6 (SD) years, and a mean follow-up of 8.5 +/- 6.3 years were interviewed and examined between May 1997 and June 1999. All case notes were carefully reviewed. Since transplantation, 16.5% of the patients had developed nonmelanoma skin cancer; 15.4%, actinic keratoses (AK); 53%, viral warts; and 1.6%, lentigo maligna melanoma (n = 3). Thirty-nine percent of the tumors were detected as a consequence of this study, and 20% of these occurred on covered body sites. The squamous cell (SCC)-basal cell carcinoma (BCC) ratio was 3.8:1. Eighty-two percent of the patients were examined a second time 12 months after the initial assessment. Using these data to identify new lesions, the annual incidence was calculated at 6.5%, increasing to 10.5% at more than 10 years posttransplantation. Duration of immunosuppression, older age at transplantation, presence of AK, male sex, and outdoor occupation were significantly associated with both SCC and BCC; SCC alone was associated with a history of having smoked tobacco. Early identification of those at greatest risk using a clinical risk profile may allow the development of more structured preventative and surveillance strategies than currently exist.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873887     DOI: 10.1053/ajkd.2000.8290

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  30 in total

1.  Skin cancer surveillance in renal transplant recipients: questionnaire survey of current UK practice.

Authors:  P N Harden; S M Reece; A A Fryer; A G Smith; H M Ramsay
Journal:  BMJ       Date:  2001-09-15

2.  Small bowel obstruction caused by metastatic squamous cell carcinoma of the skin without lymphadenopathy in a renal transplant recipient.

Authors:  Daniel A Katz; Gustavo Martinez-Mier; Stephen C Rayhill; Frank A Mitros; Subba R Kanchustambam; You Min Wu
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

3.  Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.

Authors:  M Mansh; M Binstock; K Williams; F Hafeez; J Kim; D Glidden; R Boettger; S Hays; J Kukreja; J Golden; M M Asgari; P Chin-Hong; J P Singer; S T Arron
Journal:  Am J Transplant       Date:  2015-09-03       Impact factor: 8.086

Review 4.  [Skin tumors in organ-transplant recipients].

Authors:  D Nashan; P Radny; N C Kösters; B Nashan
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

5.  Squamous cell carcinoma with rhabdoid phenotype and osteoclast-like giant cells in a renal-pancreas transplant recipient.

Authors:  K Aljerian; K O Alsaad; R Chetty; D Ghazarian
Journal:  J Clin Pathol       Date:  2006-12       Impact factor: 3.411

Review 6.  Immune profiling and cancer post transplantation.

Authors:  Christopher Martin Hope; Patrick Toby H Coates; Robert Peter Carroll
Journal:  World J Nephrol       Date:  2015-02-06

7.  Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients.

Authors:  M Lee Sanders; Jason H Karnes; Josh C Denny; Dan M Roden; T Alp Ikizler; Kelly A Birdwell
Journal:  Transplant Direct       Date:  2015-05

Review 8.  Malignancy after renal transplantation: the role of immunosuppression.

Authors:  Inés Rama; Josep M Grinyó
Journal:  Nat Rev Nephrol       Date:  2010-09       Impact factor: 28.314

Review 9.  Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.

Authors:  Kiyanna Williams; Matthew Mansh; Peter Chin-Hong; Jonathan Singer; Sarah Tuttleton Arron
Journal:  Clin Infect Dis       Date:  2013-12-20       Impact factor: 9.079

10.  GLI1 genotypes do not predict basal cell carcinoma risk: a case control study.

Authors:  Andrea Watson; Paul Kent; Murad Alam; Amy S Paller; David M Umbach; Joon Won Yoon; Philip M Iannaccone; David O Walterhouse
Journal:  Mol Cancer       Date:  2009-11-30       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.